Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (281-290 of 584) with videos related to

Pageof 59
Sort By:
Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.
Leukemia & Lymphoma|August 14, 2013
CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysisWenli Zheng, L Jeffrey Medeiros, Ken H Young, et al.
Future Oncology (London, England)|October 10, 2024
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trialEhab L Atallah, Michael J Mauro, Koji Sasaki, et al.
Veterinary Parasitology, Regional Studies and Reports|December 14, 2020
Analysis of potential risk factors of caprine coccidiosisL M R Silva, T Carrau, M J M Vila-Viçosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disordersApostolia M Tsimberidou, Dawn E Colburn, Mary Alma Welch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemiaSrdan Verstovsek, Ayalew Tefferi, Hagop Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication statusJorge E Cortes, Hagop Kantarjian, James M Foran, et al.
American Journal of Clinical Pathology|August 20, 2013
CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemiasZaher I Chakhachiro, Zhuang Zuo, Tariq N Aladily, et al.
Parasites & Vectors|April 19, 2015
First report of Anaplasma platys infection in red foxes (Vulpes vulpes) and molecular detection of Ehrlichia canis and Leishmania infantum in foxes from PortugalLuís Cardoso, Matan Gilad, Helder C E Cortes, et al.
Pageof 59

Showing results (281-290 of 584) with videos related to

Sort By:
Pageof 59
Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.
Leukemia & Lymphoma|August 14, 2013
CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysisWenli Zheng, L Jeffrey Medeiros, Ken H Young, et al.
Future Oncology (London, England)|October 10, 2024
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trialEhab L Atallah, Michael J Mauro, Koji Sasaki, et al.
Veterinary Parasitology, Regional Studies and Reports|December 14, 2020
Analysis of potential risk factors of caprine coccidiosisL M R Silva, T Carrau, M J M Vila-Viçosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disordersApostolia M Tsimberidou, Dawn E Colburn, Mary Alma Welch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemiaSrdan Verstovsek, Ayalew Tefferi, Hagop Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication statusJorge E Cortes, Hagop Kantarjian, James M Foran, et al.
American Journal of Clinical Pathology|August 20, 2013
CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemiasZaher I Chakhachiro, Zhuang Zuo, Tariq N Aladily, et al.
Parasites & Vectors|April 19, 2015
First report of Anaplasma platys infection in red foxes (Vulpes vulpes) and molecular detection of Ehrlichia canis and Leishmania infantum in foxes from PortugalLuís Cardoso, Matan Gilad, Helder C E Cortes, et al.
Pageof 59